The anticoagulant effect of therapeutic levels of dabigatran in atrial fibrillation evaluated by thrombelastography (TEG), Hemoclot Thrombin Inhibitor (HTI) assay and Ecarin Clotting Time (ECT).
Solbeck S, Jensen A, Maschmann C, Stensballe J, Ostrowski S, Johansson A. The anticoagulant effect of therapeutic levels of dabigatran in atrial fibrillation evaluated by thrombelastography (TEG), Hemoclot Thrombin Inhibitor (HTI) assay and Ecarin Clotting Time (ECT). Scand J Clin Lab Invest 2018; 78:25-30.
05.01.2018
The anticoagulant effect of therapeutic levels of dabigatran in atrial fibrillation evaluated by thrombelastography (TEG), Hemoclot Thrombin Inhibitor (HTI) assay and Ecarin Clotting Time (ECT).
05.01.2018
Scand J Clin Lab Invest 2018; 78:25-30
Solbeck Sacha, Jensen Annette Schophuus, Maschmann Christian, Stensballe Jakob, Ostrowski Sisse Rye, Johansson A
Weiter
